Pain Ease Information

Pain Ease Benefits

 DMSO & DMSO.BZ Sol- ution, Additional Info.


Order Online

Other Products

More Info

Contact Us

Glass Containers & Industrial Grade DMSO

Privacy Policy

Links Share

DMSO Master Index

How to Apply DMSO.BZ



What is DMSO?

What is DMSO?

DMSO is a simple chemical made from wood pulp that penetrates the skin and and has demonstrated the ability to promote the healing of pockets of inflammation. DMSO is an acronym for dimethylsulfoxide and can cause a minor and temporary irritation of the skin.

The U.S. Food and Drug Administration has not granted approvals for all of DMSO's many applications. Despite monumental medical research in support of DMSO's effectiveness in the treatment of soft tissue damage the FDA has restricted DMSO's application to the treatment of interstitial cystitis (bladder wall inflammation). Due to the FDA's restrictions, thousands of Americans suffering from arthrosis (joint disease) have crossed the border to receive therapeutic treatment and to purchase their own supplies of DMSO.

Many European medical communities advocate the use of DMSO as a treatment for arthritis and bursitis. In the United States, veterinary practitioners have made liberal use of DMSO for decades in the treatment of connective tissue damage, dermatological disorder, and certain immunological therapies.

Why is FDA approval withheld?

Despite decades of medical research establishing the curative power of DMSO and its free radical scavenging antioxidant properties, the FDA has not granted broad approval for its use. A close examination of the practices and policies of the FDA consistently lead to three explanatory theories.

1) In several of the instances where research has established the medical effectiveness of DMSO, the researchers have been unable to determine the exact process by which the effectiveness was achieved. In other words, they know it works but they don't all the reasons why.

2) The topical application of DMSO is followed, shortly thereafter, by a distinct "garlic like" taste in one's mouth. The inability of researchers to develop a placebo which emulates this characteristic prevents the satisfactory completion of a "double blind" study. The lack of a "double blind" study has previously been cited by the FDA as reason enough to withhold approval of a drug.

3) Sheer economics work against the widespread use of DMSO and the dissemination of information about it. Pharmaceutical companies spend millions of dollars developing, gaining approval for, and then selling drugs which remain their exclusive product for a number of years. The enormous expense of gaining FDA approval is far overshadowed by the outrageous profits a newly approved medication can generate. DMSO, however, is the relatively inexpensive by-product of the wood pulping process and has been in the public domain too long to be subject to proprietary claims. Pharmaceutical companies therefore have no incentive to bring DMSO through the approval process. In fact, the larger pharmaceutical companies, would likely prefer that DMSO were not made available so as not to interfere with the sale of their more expensive forms of therapy.

Who uses DMSO and why?

Outside of the United States DMSO is openly used, in whole or in part, in the treatment of a wide variety of ailments such as:

arthrosis (joint disease)
bursitis (the inflammation of the bursa sac)
muscular pain
interstitial cystitis (bladder wall inflammation)
tissue necrosis resulting from chemotherapy
connective tissue damage

In addition to DMSO's direct use in the treatment of the above infirmities it is also very often used as a vehicle to deliver other drugs to afflicted areas. DMSO's is widely considered ideal for this purpose because of its ability to penetrate the skin and its preferential scavenging of hydroxyl radicals.

Although spoken of in hushed tones and closed circles, DMSO is a popular form of therapy for professional athlete's suffering from bruises, swelling, and the joint pain that results from repetitive participation in their particular sport.

For many years arthritis, tendonitis , and bursitis sufferers have anecdotally reported tremendous pain relieving benefits and vastly improved range of motion derived from the topical application of DMSO to afflicted areas.

What research has been done?

Decades of exhaustive research at major institutions has incontrovertibly established the free radical scavenging properties of DMSO as an antioxidant and its ability to swiftly and safely penetrate the skin. Research also reveals that DMSO has remarkably low toxicity and that healing effects remain after DMSO has metabolized or been expelled.

Reported in 1994 by the American Physiological Society is a study conducted by Michael B. Reid and Melanie R. Moody of the Pulmonary and Critical Care section, Department of Medicine at the Baylor College of Medicine which observed that DMSO inhibits acute low frequency muscular fatigue and found that DMSO depresses contractile function of directly stimulated curarized muscle.

In November of 1995 an unrelated study was reported by Klinische Pharmakologie, Institut fur Klinische Forschung in Germany, in which 112 patients suffering from joint disease participated. 56 patients received DMSO Gel applied over a period of 3 weeks and 56 patients received a Gel Placebo applied over the same time period. The patients maintained a pain diary and ongoing medical assessments were made relating to joint pain while going about daily activities, pain at rest, and mobility were also assessed. The study conclusively found that compared to the placebo, DMSO treatment proved to have a clinically relevant analgesic (pain relieving) effect on the intensity of pain during everyday activities, at rest, and under pressure.

Yet another German study conducted by medical doctors Kneer, Kuhnau, Bias and Haag in April 1994 focused on DMSO gel in the treatment of acute tendopathies. 157 patients were randomized to treatment with either DMSO Gel applied 3 times daily or the placebo Gel excipient. Treatments were begun 72 hours after the onset of acute symptoms. Pain of movement under loading and the mobility of the joints were significantly improved after 3 days for the DMSO group. After 7 days even more significant improvements were noted. After 14 days using DMSO, 44% of the patients were completely pain free, as compared with just 9% for the placebo group. The study concluded that topical DMSO is suitably reccomended for use in the treatment of acute tenopathy since producing clinically measurable results with very little risk to the patient.

What forms of DMSO are available?

Fortunately one does not have to go to Europe or Mexico in order to acquire DMSO. DMSO is now permitted to be sold strictly as a solvent. Of course, the choice of the process used in the various applications is the sole responsibility of the user.

copyright HEALTHSOURCE © 1996 all rights reserved





DMSO.BZ Products Store Mail Address:
9942 Culver Blvd. 
P.O. Box 1026
Culver City, CA 90232-1026

Phone: (310) 398-8939